Sam-Oyerinde, Olapeju A. https://orcid.org/0000-0002-9485-0318
Onyekwelu, Onyinyechukwu M.
Musa, Kareem O.
Aribaba, Olufisayo T.
Ayo, Ibukunoluwa T.
Agboola, Sefinat A.
Idowu, Oluwatobi O.
Adenekan, Adetunji N.
Akinsola, Folasade B.
Article History
Received: 7 May 2021
Accepted: 4 October 2021
First Online: 16 October 2021
Declarations
:
: Dr. Oluwatobi O. Idowu is employed by AbbVie Inc. as a Medical Science Liaison. Other authors have no conflict interests.
: Ethical approval was gotten from LUTH Health Research Ethics Committee (ADM/DCST/HREC/APP/2716). The study adhered strictly to the tenets of the declaration of Helsinki.
: Written informed consents to participate in the study were obtained from participants after a concise but detailed explanation of the study.
: This paper is part of a dissertation submitted to the West African College of Surgeons in part fulfilment of the award of Fellowship of the West African College of Surgeons (Ophthalmology), October 2020. The findings of the study was presented in part at the World Glaucoma E-Congress, June 30–July 2, 2021.